CVS HEALTH Corp (CVS) stock

CVSNYSERetail-Drug Stores and Proprietary StoresFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 19/3030% below fair value

$89.35−0.44 (-0.49%)

Close on Nov 13, 2026Market cap $114.28BP/E 10.4Yield 2.98%

Cvs Health pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Cvs Health's pe ratio was 23.7× on Nov 11, 2026, against 211.5× a year earlier. Over the last 5 years it ranged from 10.0× to 211.5×, with a median of 18.5×.

PE Ratio at the end of each year

Period	Period end	Value	Change (pts)
2026	Nov 11, 2026	23.7×	−185.1
2025	Dec 31, 2025	208.8×	+197.4
2024	Dec 31, 2024	11.4×	−0.5
2023	Dec 29, 2023	11.9×	−25.3
2022	Dec 30, 2022	37.1×	+19.1
2021	Dec 31, 2021	18.0×	+6.7
2020	Dec 31, 2020	11.3×	−10.7
2019	Dec 31, 2019	22.0×	+0.4
2018	Dec 31, 2018	21.6×	+6.6
2017	Dec 29, 2017	15.0×	−1.9
2016	Dec 30, 2016	16.9×	−5.1
2015	Dec 31, 2015	22.0×	−2.9
2014	Dec 31, 2014	24.9×	+5.0
2013	Dec 31, 2013	19.9×	+3.4
2012	Dec 31, 2012	16.4×	+0.3
2011	Dec 30, 2011	16.2×	+2.2
2010	Dec 31, 2010	14.0×	+0.9
2009	Dec 31, 2009	13.1×	–